{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:34:01Z","timestamp":1768037641156,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["15K08627"],"award-info":[{"award-number":["15K08627"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0238-z","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T23:51:21Z","timestamp":1459554681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy"],"prefix":"10.1186","volume":"15","author":[{"given":"Hayato","family":"Tada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa-aki","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Inazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,2]]},"reference":[{"key":"238_CR1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev.bi.49.070180.003315","volume":"49","author":"P Nilsson-Ehle","year":"1980","unstructured":"Nilsson-Ehle P, Garfinkel AS, Schotz MC. Lipolytic enzymes and plasma lipoprotein metabolism. Annu Rev Biochem. 1980;49:667\u201393.","journal-title":"Annu Rev Biochem"},{"key":"238_CR2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0021-9150(00)00413-5","volume":"153","author":"T Hitsumoto","year":"2000","unstructured":"Hitsumoto T, Ohsawa H, Uchi T, Noike H, Kanai M, Yoshinuma M, et al. Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis. Atherosclerosis. 2000;153:391\u20136.","journal-title":"Atherosclerosis"},{"key":"238_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5551\/jat.9.163","volume":"9","author":"T Hitsumoto","year":"2002","unstructured":"Hitsumoto T, Yoshinaga K, Aoyagi K, Sakurai T, Kanai M, Uchi T, et al. Association between preheparin serum lipoprotein lipase mass and acute myocardial infarction in Japanese men. J Atheroscler Thromb. 2002;9:163\u20139.","journal-title":"J Atheroscler Thromb"},{"key":"238_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0021-9150(00)00394-4","volume":"153","author":"M Totsuka","year":"2000","unstructured":"Totsuka M, Miyashita Y, Ito Y, Watanabe H, Murano T, Shirai K. Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration. Atherosclerosis. 2000;153:175\u20139.","journal-title":"Atherosclerosis"},{"key":"238_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-8227(99)00063-7","volume":"46","author":"K Shirai","year":"1999","unstructured":"Shirai K, Itoh Y, Sasaki H, Totsuka M, Murano T, Watanabe H, et al. The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum. Diabetes Res Clin Pract. 1999;46:35\u201341.","journal-title":"Diabetes Res Clin Pract"},{"key":"238_CR6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5551\/jat.11.341","volume":"11","author":"K Endo","year":"2004","unstructured":"Endo K, Miyashita Y, Saiki A, Oyama T, Koide N, Ozaki H, et al. Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia. J Atheroscler Thromb. 2004;11:341\u20137.","journal-title":"J Atheroscler Thromb"},{"key":"238_CR7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","volume":"371","author":"J Crosby","year":"2014","unstructured":"TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med. 2014;371:22\u201331.","journal-title":"N Engl J Med"},{"key":"238_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","volume":"518","author":"R Do","year":"2015","unstructured":"Do R, Stitziel NO, Won HH, J\u00f8rgensen AB, Duga S, Angelica Merlini P, et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature. 2015;518:102\u20136.","journal-title":"Nature"},{"key":"238_CR9","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","volume":"365","author":"WE Boden","year":"2011","unstructured":"AIM-HIGH Investigators, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255\u201367.","journal-title":"N Engl J Med"},{"key":"238_CR10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","volume":"367","author":"GG Schwartz","year":"2012","unstructured":"Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012;367:2089\u201399.","journal-title":"N Engl J Med"},{"key":"238_CR11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","volume":"380","author":"BF Voight","year":"2012","unstructured":"Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet. 2012;380:572\u201380.","journal-title":"Lancet"},{"key":"238_CR12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","volume":"45","author":"R Do","year":"2013","unstructured":"Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45:1345\u201352.","journal-title":"Nat Genet"},{"key":"238_CR13","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","volume":"132","author":"SS Gidding","year":"2015","unstructured":"Gidding SS, Ann Champagne M, de Ferranti SD, Defesche J, Ito MK, Knowles JW, et al. The agenda for familial hypercholesterolemia: A scientific statement from the American Heart Association. Circulation. 2015;132:2167\u201392.","journal-title":"Circulation"},{"key":"238_CR14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.amjcard.2011.09.019","volume":"109","author":"MA Kawashiri","year":"2012","unstructured":"Kawashiri MA, Nohara A, Noguchi T, Tada H, Nakanishi C, Mori M, et al. Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia. Am J Cardiol. 2012;109:364\u20139.","journal-title":"Am J Cardiol"},{"key":"238_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cca.2014.07.020","volume":"440","author":"T Shirakawa","year":"2015","unstructured":"Shirakawa T, Nakajima K, Shimomura Y, Kobayashi J, Stanhope K, Havel P, et al. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism. Clin Chim Acta. 2015;440:193\u2013200.","journal-title":"Clin Chim Acta"},{"key":"238_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2014.10.029","volume":"440","author":"T Shirakawa","year":"2015","unstructured":"Shirakawa T, Nakajima K, Yatsuzuka S, Shimomura Y, Kobayashi J, Machida T, et al. The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome. Clin Chim Acta. 2015;440:123\u201332.","journal-title":"Clin Chim Acta"},{"key":"238_CR17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1373\/clinchem.2012.187914","volume":"58","author":"T Ishida","year":"2012","unstructured":"Ishida T, Miyashita K, Shimizu M, Kinoshita N, Mori K, Sun L, et al. ELISA system for human endothelial lipase. Clin Chem. 2012;58:1656\u201364.","journal-title":"Clin Chem"},{"key":"238_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/8904_2014_404","volume":"21","author":"H Tada","year":"2015","unstructured":"Tada H, Kawashiri MA, Takata M, Matsunami K, Imamura A, Matsuyama M, et al. Infantile cases of sitosterolaemia with novel mutations in the ABCG5 gene: extreme hypercholesterolaemia is exacerbated by breastfeeding. JIMD Rep. 2015;21:115\u201322.","journal-title":"JIMD Rep"},{"key":"238_CR19","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-2362.2012.02700.x","volume":"42","author":"H Tada","year":"2012","unstructured":"Tada H, Kawashiri MA, Tanaka A, Nakano T, Nakajima K, Inoue T, et al. Post-prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia. Eur J Clin Invest. 2012;42:1094\u20139.","journal-title":"Eur J Clin Invest"},{"key":"238_CR20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","volume":"45","author":"P Deloukas","year":"2013","unstructured":"CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25\u201333.","journal-title":"Nat Genet"},{"key":"238_CR21","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2015.03.544","volume":"65","author":"GG Schwartz","year":"2015","unstructured":"Schwartz GG, Abt M, Bao W, DeMicco D, Kallend D, Miller M, et al. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins. J Am Coll Cardiol. 2015;65:2267\u201375.","journal-title":"J Am Coll Cardiol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0238-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T05:52:33Z","timestamp":1498283553000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0238-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0238-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,2]]},"article-number":"66"}}